greeksoup/ stock research

Johnson & Johnson (JNJ) FY2015 results: revenue $70.1 billion, down 5.7% on the year

Johnson & Johnson (JNJ) reported revenue of $70.1 billion for fiscal 2015, the year ended 3 January 2016, down 5.7% on the year before. Net income was $15.4 billion, down 5.6%, and diluted earnings per share $5.48. The figures are the company's own, from the 10-K it filed with the SEC on 24 February 2016.

Revenue
$70.1 billion
-5.7% on the year
FY2008FY2015
Operating margin
n/a
29.0% a year earlier
FY2008FY2015
Net income
$15.4 billion
-5.6% on the year
FY2008FY2015
Diluted EPS
$5.48
-3.9% on the year
FY2008FY2015

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2015FY2014FY2013On the yearLast 8 years
Revenue70,07474,33171,312-5.7%
Cost of revenue21,53622,74622,342-5.3%
Gross profit48,53851,58548,970-5.9%
Gross margin69.3%69.4%68.7%
Research and development9,0468,4948,183+6.5%
Selling, general and administrative21,20321,95421,830-3.4%
Operating incomen/a21,59016,412
Operating marginn/a29.0%23.0%
Interest expense552533482+3.6%
Pre-tax income19,19620,56315,471-6.6%
Income tax3,7874,2401,640-10.7%
Effective tax rate19.7%20.6%10.6%
Net income15,40916,32313,831-5.6%
Net margin22.0%22.0%19.4%
Diluted EPS$5.48$5.70$4.81-3.9%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2015FY2014FY2013On the yearLast 8 years
Operating cash flow19,56918,71017,414+4.6%
Capital expenditure3,4633,7143,595-6.8%
Free cash flow16,10614,99613,819+7.4%
Free cash flow margin23.0%20.2%19.4%
Cash from investing-7,735-12,305-5,103
Cash from financing-11,136-12,499-6,091
Depreciation and amortisation3,7463,8954,104-3.8%
Share-based compensation874792728+10.4%
Buybacks5,2907,1243,538-25.7%
Dividends paid8,1737,7687,286+5.2%
Dividend per share$2.95$2.76$2.59+6.9%
Diluted shares, weighted2,813m2,864m2,877m-1.8%

Balance sheet

$ millionFY2015FY2014FY2013On the yearLast 8 years
Shareholders' equity71,15069,75274,053+2.0%
Debt19,86118,76018,180+5.9%
Other liabilities42,40041,84640,450+1.3%
Total liabilities and equity133,411130,358132,683+2.3%
Fixed assets15,90516,12616,710-1.4%
Goodwill21,62921,83222,798-0.9%
Intangible assets25,76427,22227,947-5.4%
Investments24,64418,5668,279+32.7%
Cash and equivalents13,73214,52320,927-5.4%
Receivables10,73410,98511,713-2.3%
Inventory8,0538,1847,878-1.6%
Other assets12,95012,92016,431+0.2%
Total assets133,411130,358132,683+2.3%

10-K for the year ended 3 January 2016, filed 24 February 2016: the filing.